Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000277.3(PAH):c.241_256del (p.Thr81fs)

CA229499

102638 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 9c0824e1-2710-46f7-8a21-a59b73ada7a0

HGVS expressions

NM_000277.3:c.241_256del

NM_000277.3(PAH):c.241_256del (p.Thr81fs)

NM_000277.1:c.241_256del

NM_000277.2:c.241_256del

NM_001354304.1:c.241_256del

NM_001354304.2:c.241_256del

ENST00000307000.7:c.226_241del

ENST00000546844.1:c.241_256del

ENST00000548677.2:n.328_343del

ENST00000548928.1:n.163_178del

ENST00000549111.5:n.337_352del

ENST00000550978.6:n.225_240del

ENST00000551337.5:c.241_256del

ENST00000551988.5:n.330_345del

ENST00000553106.5:c.241_256del

NC_000012.12:g.102894832_102894847del

CM000674.2:g.102894832_102894847del

NC_000012.11:g.103288610_103288625del

CM000674.1:g.103288610_103288625del

NC_000012.10:g.101812740_101812755del

NG_008690.1:g.27757_27772del

NG_008690.2:g.68565_68580del

Pathogenic

PP4_Moderate PVS1 PM2 PM3

Evidence Links 2

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

This c.241_256del (p.Thr81fs) variant in PAH has been reported in two patients with PKU, observed with two pathogenic variants: p.R241C, phase unknown (PMID: 14722928) and with p.V399V, phase unknown (PMID: 24401910). This variant is absent from controls is population databases. This is a frameshift variant in exon 3 out of 13 coding exons. The variant is predicted to undergo nonsense mediated mRNA decay (NMD), as it is not located in the 3’-most exon or the 3’-most 50 bp of the penultimate exon. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PM2, PP4_moderate, and PM3.

PP4_Moderate

Observed in a patient with mild PKU (Phe = 851 µmol/L). 6R-BH4 was ruled out based on analyses of urinary pterins, dihydropteridine reductase activity in erythrocytes, and PTPS gene mutation. PMID: 14722928

PubMed:14722928

PVS1

This is a frameshift variant in exon 3 out of 13 coding exons. The variant is predicted to undergo nonsense mediated mRNA decay (NMD), as it is not located in the 3’-most exon or the 3’-most 50 bp of the penultimate exon. The exon is present in biologically-relevant transcripts. Loss of function is a known mechanism of disease: 175 pathogenic null variants reported in Clinvar across 13 different exons, 20 of which are in exon 3.

PM2

This variant is absent from controls in gnomAD and ExAC.

PM3

[p.T81_R86>VfsX6; p.V399V]. When sequence alteration was identified, paternal or maternal origin was determined whenever the parental DNA was available. PMID: 24401910. p.[T81fsX6; R241C]. Segregation analysis was not done, so phase is unknown. PMID: 14722928

PubMed:24401910

Approved on: 2020-10-22

Published on: 2020-10-22

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.